Bluejay Diagnostics, Inc.
BJDX- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001704287
In the last 90 days, Bluejay Diagnostics, Inc. insiders filed 1 open-market purchase and 1 sale; 8 institutions reported holding it in 13F filings for Q2 2026, worth $259.3K in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Bluejay Diagnostics, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 4 | 5 | +1 |
| Shares | 2.58K | 99.0K | +96.4K (+3,744.5%) |
| Value | $9.61K | $170.3K | +$160.7K (+1,672.8%) |
New holders (2)
Institutions that held Bluejay Diagnostics, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sabby Management, LLC | 96,033 | $165.2K | 1.27% |
| Citigroup Inc | 241 | $415 | 0.00% |
Sold out (1)
Institutions that held Bluejay Diagnostics, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| SBI Securities Co., Ltd. | 20 | $75 |